Open cases
7
In intake or review
Serious ICSRs
4
15-day expedited clock
Due ≤ window/3
1
Approaching or past deadline
Auto-processed
8
1 submitted to date
Case queue
AI-drafted from source. Every case is human-reviewed before submission.| Case | Primary event | Source | Seriousness | Status | Deadline | Received |
|---|
ICSR-2026-0417 | Anaphylactic reactionImmune system disorders | Email | Serious | Needs review | 3d left | 02 Jul 2026 |
ICSR-2026-0412 | RhabdomyolysisMusculoskeletal and connective tissue disorders | Email | Serious | Needs review | 9d left | 08 Jul 2026 |
ICSR-2026-0431 | Drug reaction with eosinophilia and systemic symptomsImmune system disorders | Literature | Serious | Needs review | 13d left | 12 Jul 2026 |
ICSR-2026-0429 | Serotonin syndromeNervous system disorders | Email | Serious | Needs review | 13d left | 12 Jul 2026 |
ICSR-2026-0428 | NauseaGastrointestinal disorders | Call centre | Non-serious | Approved | 78d left | 02 Jul 2026 |
ICSR-2026-0419 | Injection site reactionGeneral disorders and administration site conditions | Email | Non-serious | Approved | 81d left | 05 Jul 2026 |
ICSR-2026-0424 | Vitamin B12 deficiencyMetabolism and nutrition disorders | Call centre | Non-serious | Needs review | 86d left | 10 Jul 2026 |
ICSR-2026-0408 | Gastrointestinal haemorrhageGastrointestinal disorders | Partner | Serious | Submitted | Submitted | 22 Jun 2026 |